CCR3 — Drug Target
All drugs that target CCR3 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (2)
- SB213503 lot 3 · GlaxoSmithKline · CCR3 antagonist · Respiratory/Immunology
SB213503 is a selective antagonist of the chemokine receptor CCR3, which blocks eosinophil recruitment and activation in inflammatory airway diseases. - SB213503 lot 1 · GlaxoSmithKline · CCR3 antagonist · Respiratory / Immunology
SB213503 is a selective antagonist of the chemokine receptor CCR3, which blocks eosinophil recruitment and activation in inflammatory airway diseases.